Related Experiment Videos
Vitamin K prophylaxis: leaving the old route for the new one?
Francesco Tandoi1, Fabio Mosca, Massimo Agosti
1Neonatal Intensive Care Unit, Del Ponte Hospital, Varese, Italy.
Insights
Vitamin K prophylaxis prevents early newborn bleeding, but remains a global concern, especially for breastfed infants. This review examines vitamin K
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
Background:
- Vitamin K deficiency bleeding (VKDB) is a preventable condition in newborns.
- Current prophylaxis involves oral or parenteral vitamin K administration.
- Concerns persist regarding the effectiveness of vitamin K prophylaxis, particularly in exclusively breastfed infants.
Purpose of the Study:
- To review the current evidence and practices for vitamin K prophylaxis in newborns.
- To discuss the ongoing challenges and considerations in preventing early and late VKDB.
Main Methods:
- Literature review of studies on vitamin K prophylaxis and VKDB.
- Analysis of current clinical guidelines and recommendations.
Main Results:
- Vitamin K administration is effective in preventing early VKDB.
- Late VKDB remains a concern, especially in certain infant populations.
- Breastfeeding is a significant risk factor for late VKDB.
Conclusions:
- Vitamin K prophylaxis is crucial for preventing neonatal hemorrhage.
- Further research and optimized strategies are needed to address late VKDB, particularly in breastfed infants.
Abstract:
Oral or parenteral administration of vitamin K is the accepted practice for prevention of early vitamin K deficiency bleeding (VKDB) in the newborn. However, vitamin K prophylaxis in the newborn continues to be a worldwide health concern, particularly in breastfed infants. This paper reviews the current status of the use of vitamin K for the prevention of early and late VKDB.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Routes of Drug Administration: Enteral
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Routes of Drug Administration: Overview
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
Venous Thrombosis III: Interprofessional Care